NYBC Ventures — Full Portfolio

Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products.

Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesAnn Arbor, US

Kalyan Handique(Executive Officer, Director)John Younger(Executive Officer, Director)inJames Militello(Executive Officer)

BoardJeffrey S. Williams(Director)Paul D'Amato(Director)Dan Kidle(Director)in

Co-investorsArboretum VenturesBeringeaBerkeley CatalystBlueStone Venture PartnerseLab VenturesID Ventures+5 more

Aronora is a clinical-stage biotech developing antithrombotic therapies, including factor XI/XIa inhibitors and thrombolytic drug candidates, to treat and manage thrombotic and thromboembolic conditions such as acute ischemic stroke, heart attack, and pulmonary embolism.

BiotechDeep TechHealthtechPortland, US

Erik I. Tucker(President & Chief Executive Officer)in

AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.

BiotechLongevityMedical Devices

Andrew Schiermeier(Chief Executive Officer)in

Co-investorsNovo HoldingsBlackstone Life SciencesEight Roads VenturesF-Prime Capital

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.

BiotechDeep TechHealthtechBerkeley, US

Marco Lobba, Ph.D.(Founder)in

Co-investorsFREEFLOWLongeVC

Cellular Origins provides automated cell therapy manufacturing solutions through its Constellation platform, which integrates robotics and digital management to enable GMP-compliant scaling of cell therapies with minimal process modification.

Advanced ManufacturingBiotechRoboticsCambridge, GB

Co-investorsHighland EuropeTTP Ventures

A blood bank and laboratory services provider supplying blood products including red blood cells, plasma, and platelets to hospitals and medical facilities, alongside laboratory testing services and specialty clinical procedures.

BiotechHealthtechMedical DevicesNew York, US

Functional Fluidics is a CLIA-certified diagnostic lab offering proprietary red blood cell function biomarker assays, starting with Sickle Cell Disease.

BiotechDigital HealthHealthtechMedical DevicesDetroit, US

Patrick Hines(CEO & Founder)inDr. Hines(Founder)John Cunningham(Chief Operating Officer)in

Co-investorsID VenturesMichigan RiseSeae VenturesWavemaker Three-Sixty Health

A healthcare-focused investment firm managing approximately $2 billion in assets across 52 portfolio companies.

Digital HealthHealthtechMedical Devices

Co-investorsUnion Grove Venture Partners

Immusoft develops a cell therapy platform called Immune System Programming (ISP) that engineers a patient's B cells into plasma cells that produce therapeutic proteins after being infused back into the patient.

BiotechDeep TechHealthtechSeattle, US

Matthew Scholz(Founder)Sean Ainsworth(Chief Executive Officer)Robert Sikorski(Chief Medical Officer)Rob Hayes(Chief Scientific Officer)inScott McIvor(Chief Development Officer)Eric Garcia(Executive Officer)

Co-investorsBioRock VenturesBoston Harbor AngelsBreakout VenturesEQx FundInvariantes FundMichigan Capital Network+1 more

KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.

BiotechDeep TechHealthtechMedical DevicesBaltimore, US

Allan Doctor(Co-Founder & CSO)inDipanjan Pan(Co-Founder, Chief Technical Officer)inPhilip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)

Co-investorsBioAdvanceBioGenerator VenturesMaryland TEDCOOld Line Capital PartnersTEDCO

Star Therapeutics develops treatments aimed at addressing real-world patient needs.

BiotechSouth San Francisco, US

Adam Rosenthal(Founder & CEO)inNancy Stagliano(Director)Michelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)Scott Robertson(Executive Officer)inGary Patou(Executive Officer)in

Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesAgent Capital+8 more

Thymmune Therapeutics develops a machine learning-driven thymic cell engineering platform that mass-produces iPSC-derived thymic cells to restore immune function affected by aging and disease.

AI & Machine LearningBiotechLongevityCambridge, US

Stan Wang(MD, PhD)inBing Lim(MD, PhD)inManish Jainin

Co-investorsPillar VC

Vitestro is a Netherlands-based medical robotics company that develops Aletta, an autonomous robotic phlebotomy device for diagnostic blood collection in hospitals and laboratories.

HealthtechMedical DevicesRoboticsNetherlands, NL

Toon Overbeeke(Co-founder & CEO)inBrian Joseph(Co-founder)in

Co-investorsSonder Capital